Aspira Women's Health Inc. Common Stock
AWH was delisted on the 16th of April, 2025.
62 hedge funds and large institutions have $91.5M invested in Aspira Women's Health Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8,061% more call options, than puts
Call options by funds: $1.88M | Put options by funds: $23K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$45.8M |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
+$14.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
| 4 |
BlackRock
New York
|
+$10.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.47M |
Top Sellers
AWH Hedge Fund Activity: Q2 2020 in Review
62 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Aspira Women's Health Inc. Common Stock (AWH) for Q2 2020, worth a combined $91.5M.
Buyers outnumbered sellers: 62 funds opened new AWH positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Oracle Investment Management, opening a new position worth an estimated $45.8M.
- 62 institutional investors held Aspira Women's Health Inc. Common Stock (AWH) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $91.5M of Aspira Women's Health Inc. Common Stock stock for Q2 2020.
- 62 funds opened new Aspira Women's Health Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +62 holders.
- The largest Aspira Women's Health Inc. Common Stock buyer in Q2 2020 was Oracle Investment Management, an estimated $45.8M added.
Based on aggregated 13F filings for Q2 2020.